US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPUS GENETICS INC

6.04

-0.0300-0.49%

Post-market: 5.95-0.0861-1.43%19:58 EDT

Volume:4.66M

Turnover:28.44M

Market Cap:502.50M

PE:-4.67

High:6.58

Open:6.16

Low:5.77

Close:6.07

52wk High:7.07

52wk Low:1.35

Shares:83.20M

Float Shares:65.21M

Volume Ratio:0.33

T/O Rate:7.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2925

EPS(LYR):-0.8000

ROE:-4796.52%

ROA:-48.06%

PB:-38.70

PE(LYR):-7.55

Loading ...

Overview Company News Filings

LifeSci Capital Remains a Buy on Opus Genetics (IRD)

Opus Genetics Posts OPGx-BEST1 Phase 1/2 Low-Dose Cohort Presentation

Health Rounds: Experimental Eye Drops Ease Night Vision Problems for Drivers

Thomas Shrader Reiterates Buy on IRD, Maintains $12 Price Target Amid Encouraging Clinical and Regulatory Progress

Opus Genetics up over 32%, on Track for Largest Percent Increase Since February 2020

Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress

Top Midday Gainers

MT Newswires Live

U.S. Stocks on the MOVE-Apple, Omnicom, Jersey Mike's Subs

Opus Genetics price target raised to $16 from $13 at Chardan

Wedbush Raises Opus Genetics Price Target to $13 From $10, Maintains Outperform Rating

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)

Opus Genetics Price Target Maintained with a $13.00/Share by Chardan Capital

Opus Genetics Reports Positive Phase 1/2 Low-Dose Cohort 1 Data for OPGx-BEST1 Gene Therapy in BEST1 Retinal Disease

Opus Genetics - FDA Aligns on ≥3 Decibels Microperimetry Improvement as Potential Pivotal Endpoint

THOMSON REUTERS

Opus Genetics - Opgx-Best1 Demonstrates Favorable Safety with no Serious Adverse Events or Dose-Limiting Toxicities

THOMSON REUTERS

Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of Opgx-Best1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027

THOMSON REUTERS

Opus Genetics - Cohort 2 Dosing to Complete in Q4 2026, Topline Data Expected Q2 2027

THOMSON REUTERS

Opus Genetics - All Five Participants Show Clinically Meaningful Improvement in Visual Function

THOMSON REUTERS

Opus Genetics to Report Phase 1/2 Cohort 1 Topline Data for OPGx-BEST1 Gene Therapy Sept. 9 Webcast

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/IRD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":6.04,"timestamp":1789156800000,"preClose":6.07,"halted":0,"volume":4658018,"hourTrading":{"tag":"盘后","latestPrice":5.9539,"preClose":6.04,"latestTime":"19:58 EDT","volume":24465,"amount":146770.7306,"timestamp":1789171082109,"change":-0.0861,"changeRate":-0.014255,"amplitude":0.034768},"delay":0,"changeRate":-0.004942339373970386,"floatShares":65209799,"shares":83195823,"eps":-1.292468,"marketStatus":"Market Closed","change":-0.03,"latestTime":"09-11 16:00:00 EDT","open":6.16,"high":6.576,"low":5.77,"amount":28443586.032678,"amplitude":0.132784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.292468,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":6.07,"preHourTrading":{"tag":"盘前","latestPrice":6.16,"preClose":6.07,"latestTime":"09:26 EDT","volume":27381,"amount":166695.41847600002,"timestamp":1789133170803,"change":0.09,"changeRate":0.014827,"amplitude":0.054366},"postHourTrading":{"tag":"盘后","latestPrice":5.9539,"preClose":6.04,"latestTime":"19:58 EDT","volume":24465,"amount":146770.7306,"timestamp":1789171082109,"change":-0.0861,"changeRate":-0.014255,"amplitude":0.034768},"volumeRatio":0.3337138860562516,"optionData":{"bulkOrders":[{"symbol":"IRD","call":true,"expireDate":1789704000000,"strike":"7.5","timestamp":1789137478614,"price":0.15,"volume":2000,"amount":30000,"type":"+"},{"symbol":"IRD","call":true,"expireDate":1789704000000,"strike":"5.0","timestamp":1789137478614,"price":1.15,"volume":1062,"amount":122130,"type":"-"}]},"impliedVol":1.3364,"impliedVolPercentile":0.4064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":65209799,"roa":"-48.06%","roe":"-4796.52%","lyrEps":-0.8,"volumeRatio":0.3337138860562516,"shares":83195823,"dividePrice":0,"high":6.576,"amplitude":0.132784,"preClose":6.07,"low":5.77,"week52Low":1.35,"pbRate":"-38.70","psRate":"50.98","week52High":7.07,"institutionHeld":0,"latestPrice":6.04,"eps":-1.292468,"divideRate":0,"volume":4658018,"delay":0,"ttmEps":-1.292468,"open":6.16,"prevYearClose":2.01,"prevWeekClose":4.67,"prevMonthClose":3.62,"prevQuarterClose":4.11,"fiveDayClose":4.6,"twentyDayClose":3.72,"sixtyDayClose":3.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"IRD","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-05-12","symbol":"IRD","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-10","symbol":"IRD","fiscalQuarterEnding":"2025/12","expectedEps":-0.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.7222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7222,"analysts":18,"updateTime":1785384000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-09-11","current":-4.67323,"percent":0.100858,"low":-8.249622,"twenty":-3.069117,"median":-2.01221,"eighty":-1.133546,"high":-0.560128,"avg":-2.403121,"sd":1.785424,"marketCap":504998645},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-13","current":-3.427836,"twenty":-2.136977,"median":-1.323479,"eighty":-1.031375,"marketCap":233788665},{"date":"2026-02-20","current":-3.609844,"twenty":-2.149226,"median":-1.323479,"eighty":-1.038117,"marketCap":246202222},{"date":"2026-02-27","current":-3.630068,"twenty":-2.153773,"median":-1.330709,"eighty":-1.044184,"marketCap":247581506},{"date":"2026-03-06","current":-4.823238,"twenty":-2.163754,"median":-1.335088,"eighty":-1.055298,"marketCap":328959272},{"date":"2026-03-13","current":-6.821589,"twenty":-2.163832,"median":-1.335088,"eighty":-1.05838,"marketCap":338289413},{"date":"2026-03-20","current":-6.571003,"twenty":-2.174573,"median":-1.340893,"eighty":-1.062543,"marketCap":325862626},{"date":"2026-03-27","current":-6.48492,"twenty":-2.196211,"median":-1.358307,"eighty":-1.072721,"marketCap":321593683},{"date":"2026-04-02","current":-6.728822,"twenty":-2.279157,"median":-1.369917,"eighty":-1.078827,"marketCap":333689021},{"date":"2026-04-10","current":-7.890943,"twenty":-2.31549,"median":-1.383164,"eighty":-1.078974,"marketCap":391319747},{"date":"2026-04-17","current":-8.249622,"twenty":-2.347317,"median":-1.393136,"eighty":-1.079587,"marketCap":409107008},{"date":"2026-04-24","current":-7.474875,"twenty":-2.424764,"median":-1.39894,"eighty":-1.079843,"marketCap":370686524},{"date":"2026-05-01","current":-7.357517,"twenty":-2.49456,"median":-1.404745,"eighty":-1.081468,"marketCap":364866631},{"date":"2026-05-08","current":-7.717474,"twenty":-2.527902,"median":-1.450845,"eighty":-1.086096,"marketCap":382717249},{"date":"2026-05-15","current":-3.318654,"twenty":-2.605325,"median":-1.471353,"eighty":-1.089005,"marketCap":354870285},{"date":"2026-05-22","current":-2.864592,"twenty":-2.625631,"median":-1.50381,"eighty":-1.089833,"marketCap":306316604},{"date":"2026-05-29","current":-2.804496,"twenty":-2.764432,"median":-1.520037,"eighty":-1.093147,"marketCap":299890382},{"date":"2026-06-05","current":-3.098301,"twenty":-2.804496,"median":-1.567278,"eighty":-1.099183,"marketCap":331307470},{"date":"2026-06-12","current":-2.976252,"twenty":-2.841362,"median":-1.641006,"eighty":-1.10936,"marketCap":318256557},{"date":"2026-06-18","current":-3.09043,"twenty":-2.862186,"median":-1.648544,"eighty":-1.10936,"marketCap":330465888},{"date":"2026-06-26","current":-2.831626,"twenty":-2.921273,"median":-1.671763,"eighty":-1.117502,"marketCap":302791405},{"date":"2026-07-02","current":-3.181773,"twenty":-2.964753,"median":-1.703207,"eighty":-1.119538,"marketCap":340233353},{"date":"2026-07-10","current":-3.103979,"twenty":-3.005472,"median":-1.779688,"eighty":-1.123486,"marketCap":331914656},{"date":"2026-07-17","current":-2.5326,"twenty":-2.998741,"median":-1.85001,"eighty":-1.127372,"marketCap":270815938},{"date":"2026-07-24","current":-2.254631,"twenty":-2.977774,"median":-1.874663,"eighty":-1.129113,"marketCap":241092238},{"date":"2026-07-31","current":-2.964995,"twenty":-2.973207,"median":-1.900983,"eighty":-1.129716,"marketCap":317052806},{"date":"2026-08-07","current":-2.854241,"twenty":-2.967182,"median":-1.931317,"eighty":-1.129716,"marketCap":307144906},{"date":"2026-08-14","current":-2.87602,"twenty":-2.967182,"median":-1.947379,"eighty":-1.129716,"marketCap":309488461},{"date":"2026-08-21","current":-3.185269,"twenty":-2.973207,"median":-1.951541,"eighty":-1.129716,"marketCap":342766790},{"date":"2026-08-28","current":-2.976526,"twenty":-2.991855,"median":-1.986619,"eighty":-1.13016,"marketCap":320303918},{"date":"2026-09-04","current":-3.556368,"twenty":-3.015947,"median":-2.002099,"eighty":-1.13167,"marketCap":382700785},{"date":"2026-09-11","current":-4.69286,"twenty":-3.069117,"median":-2.01221,"eighty":-1.133546,"marketCap":504998645}],"updateTime":1789321984142},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667502247","title":"LifeSci Capital Remains a Buy on Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667502247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667502247?lang=en_us&edition=fundamental","pubTime":"2026-09-13 01:15","pubTimestamp":1789233314,"startTime":"0","endTime":"0","summary":"In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on Opus Genetics, with a price target of $20.00. Briseb...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666226575","title":"Opus Genetics Posts OPGx-BEST1 Phase 1/2 Low-Dose Cohort Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666226575","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666226575?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:50","pubTimestamp":1789131017,"startTime":"0","endTime":"0","summary":"Opus Genetics posts OPGx-BEST1 Phase 1/2 low-dose cohort presentationOpus Genetics released 3-month results from the low-dose Cohort 1 of its Phase 1/2 OPGx-BEST1 gene therapy study.Low-dose cohort re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL5bpnMC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666181055","title":"Health Rounds: Experimental Eye Drops Ease Night Vision Problems for Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666181055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666181055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 03:20","pubTimestamp":1789068011,"startTime":"0","endTime":"0","summary":"Health Rounds: Experimental eye drops ease night vision problems for driversSept 10 -Hello Health Rounds readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N4520WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666145562","title":"Thomas Shrader Reiterates Buy on IRD, Maintains $12 Price Target Amid Encouraging Clinical and Regulatory Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666145562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666145562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:15","pubTimestamp":1789035355,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Opus Genetics, with a price target of $12.00. Thomas Shrader ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/thomas-shrader-reiterates-buy-on-ird-maintains-12-price-target-amid-encouraging-clinical-and-regulatory-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/thomas-shrader-reiterates-buy-on-ird-maintains-12-price-target-amid-encouraging-clinical-and-regulatory-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666012532","title":"Opus Genetics up over 32%, on Track for Largest Percent Increase Since February 2020","url":"https://stock-news.laohu8.com/highlight/detail?id=2666012532","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666012532?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:46","pubTimestamp":1788979560,"startTime":"0","endTime":"0","summary":"Opus Genetics, Inc.  is currently at $5.74, up $1.40 or 32.14%--Would be highest close since April 17, 2026, when it closed at $5.75--On pace for largest percent increase since Feb. 11, 2020, when it rose 79.31%--Currently up five of the past six days--Up 58.43% month-to-date--Up 185.32% year-to-date--Down 99.94% from its all-time closing high of $10080.00 on Dec. 15, 2004--Up 331.2% from 52 weeks ago , when it closed at $1.33--Down 0.26% from its 52-week closing high of $5.75 on April 17, 2026--Up 331.2% from its 52-week closing low of $1.33 on Sept. 10, 2025--Traded as high as $7.07; highest intraday level since April 5, 2021, when it hit $7.28--Up 62.9% at today's intraday high; largest intraday percent increase since June 2, 2025, when it rose as much as 75.97%All data as of 2:44:02 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666162532","title":"Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666162532","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666162532?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:08","pubTimestamp":1788977280,"startTime":"0","endTime":"0","summary":"Shares of Opus Genetics, which focuses on inherited retinal diseases, reached a 52-week high as it reported favorable drug study data and a successful meeting with the Food and Drug Administration.The","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4588","LABU","BK4097","PRGS","LU2065732104.USD","BK4585","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532138","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532138","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532138?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:05","pubTimestamp":1788977158,"startTime":"0","endTime":"0","summary":"SUNation Energy  shares surged 60% after Suniva reported late Tuesday the close of an $835 million capital raise. The duo struck a reverse merger deal in June.Intraday trading volume catapulted to over 70.8 million from a daily average of about 2.5 million.InnovAge  swung to a profit in fiscal Q4 following a better-than-expected sales growth.Shares jumped 8%, with intraday trading volume rising to over 612,000 from a daily average of about 317,000.Opus Genetics  said Wednesday patients with BEST1-related retinal diseases showed clinically meaningful improvement in visual function in the low-dose cohort 1 of its BIRD-1 phase 1/2 clinical trial evaluating OPGx-BEST1.Wedbush Securities raised its price target for the stock to $13 from $10 while maintaining its outperform rating.Shares surged 25% as intraday trading volume soared to over 43.6 million from a daily average of roughly 1.1 million.Price: 3.85, Change: +1.48, Percent Change: +62.24","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7129","IRD","ORBX","IRDM","BK4096","COWG","BK4139","BK4196","LU0054578231.USD","MARS","BK4089","WARP","BK4007","DIPR","SUNE","XTL","INNV","BK4564","IRD.AU","ROKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532640","title":"U.S. Stocks on the MOVE-Apple, Omnicom, Jersey Mike's Subs","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532640","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532640?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:54","pubTimestamp":1788976474,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's SubsSeptember 9  (Reuters)-The main U.S. stock indexes fell on Wednesday as oil prices soared past $100 a barrel and Treasury yields rose, pu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4510Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRT","META","OXY","VTRS","IXN","VDE","AAPL","CASY","CMPS","EVMN","JILL","BKKT","CHWY","TH","SMMT","LFST","TTAN","ABNB","SIG","DIG","SUNB","WLK","IRD","XOMX","UNH","CGNT","SAIL","CHYM","COP","INGM","BKV","EAF","METU","OGIG","SFD","TBBK","BKNG","CI","OMC","TRUC","DOW","KFY","LYFT","CVX","ASO","UGI","XOM","TYRA","GAMR","IXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666329645","title":"Opus Genetics price target raised to $16 from $13 at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666329645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666329645?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:40","pubTimestamp":1788975649,"startTime":"0","endTime":"0","summary":"Chardan analyst Andreas Argyrides raised the firm’s price target on Opus Genetics (IRD) to $16 from $13 and keeps a Buy rating on the shares follow...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-price-target-raised-to-16-from-13-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-price-target-raised-to-16-from-13-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4548","BK4585","BK4535","BK4568","BK4139","BNTX","BK4551","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534593","title":"Wedbush Raises Opus Genetics Price Target to $13 From $10, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666534593?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:34","pubTimestamp":1788971698,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) has an average rating of buy and mean price target of $10.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IRD","IRD.AU","BK4007","BK7129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666053135","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666053135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666053135?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:10","pubTimestamp":1788966623,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pyxis Oncology (PYXS) and Opus Genetics (IRD). Pyxis Oncology (PY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","PYXS","BK4585","IRD","HCSG","LU0128526141.USD","BK4581","BK4137","BK4007","LU0029874061.USD","PY","BK4139","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666953360","title":"Opus Genetics Price Target Maintained with a $13.00/Share by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666953360?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:39","pubTimestamp":1788957540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587680","title":"Opus Genetics Reports Positive Phase 1/2 Low-Dose Cohort 1 Data for OPGx-BEST1 Gene Therapy in BEST1 Retinal Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587680","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587680?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:06","pubTimestamp":1788952005,"startTime":"0","endTime":"0","summary":"Opus Genetics reports positive Phase 1/2 low-dose Cohort 1 data for OPGx-BEST1 gene therapy in BEST1 retinal diseaseOpus Genetics reported positive early results from the low-dose Cohort 1 of its Phas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbCMFnJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014005.SGD","LU2210149790.SGD","NDAQ","SG9999014021.USD","IRD","BK4585","LU0314104364.USD","BK4112","BCDF","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","BK4588","SG9999014013.SGD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","BK4139","IE00BQXX3F31.USD","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666820505","title":"Opus Genetics - FDA Aligns on ≥3 Decibels Microperimetry Improvement as Potential Pivotal Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2666820505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666820505?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAJYCGT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666820295","title":"Opus Genetics - Opgx-Best1 Demonstrates Favorable Safety with no Serious Adverse Events or Dose-Limiting Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2666820295","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666820295?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAJYCGT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666069582","title":"Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of Opgx-Best1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666069582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666069582?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAJYCGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666042582","title":"Opus Genetics - Cohort 2 Dosing to Complete in Q4 2026, Topline Data Expected Q2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666042582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666042582?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAJYCGT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666028582","title":"Opus Genetics - All Five Participants Show Clinically Meaningful Improvement in Visual Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2666028582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666028582?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAJYCGT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815949","title":"Opus Genetics to Report Phase 1/2 Cohort 1 Topline Data for OPGx-BEST1 Gene Therapy Sept. 9 Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815949?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:01","pubTimestamp":1788346876,"startTime":"0","endTime":"0","summary":"Opus Genetics to report Phase 1/2 Cohort 1 topline data for OPGx-BEST1 gene therapy Sept. 9 webcastOpus Genetics set a Sept. 9, 2026 investor webcast to present topline Phase 1/2 Cohort 1 data for OPG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2m3155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4007","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","IRD","BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","SG9999014005.SGD","NDAQ","SG9999014039.USD","BK4139","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","BK4585","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747820","title":"Longeveron Appoints Nirav Jhaveri as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747820","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747820?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nTUA3CJNSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DERM","LGVN","03696","BK1141","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":121,"code":"91000000","status":"200"}]}}